You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.
Supplements and COVID19

Supplements and COVID19

Press release from 2021/02/09

5-Aminolevulinic acid (5-ALA) has been found to suppress infection of the causative virus of the new coronavirus infection (COVID-19) -Expected as a candidate for future therapeutic agents-

This time, Nagasaki University

* 1 (1-14 Bunkacho, Nagasaki City, Nagasaki Prefecture, President Shigeru Kono: Nagasaki University) and Neopharma Japan Co., Ltd.

* 2 (2-10-2 Fujimi, Chiyoda-ku, Tokyo, Representative Director) Satoshi Kawada: NPJ) conducted an infection experiment in cultured cells using SARS-CoV-2, which is the causative virus of the new coronavirus infection (“COVID-19”). As a result, 5-aminolevulinic acid We have discovered a strong infection-suppressing effect of

* 3 (hereinafter, "5-ALA"). This research was officially published in the international academic journal "Biochemical and Biophysical Research Communications" on February 8, 2021 (Japan time). Nagasaki University and NPJ released on October 29, 2020

* 4 There is an urgent need to develop effective treatments for the current spread of COVID-19 infection. 5-ALA is a naturally synthesized amino acid that is used for various purposes such as anti-cancer therapy and health foods due to its high bioavailability.

In this study, we showed that 5-ALA strongly suppresses infection with SARS-CoV-2, the causative virus of COVID-19, in cultured cells. This antiviral effect was observed in both human and non-human cells without overt cytotoxicity.

Therefore, 5-ALA is considered to be worth further research as a candidate for antiviral drug against COVID-19.

Supplements and COVID19

Press release from 2021/02/09

5-Aminolevulinic acid (5-ALA) has been found to suppress infection of the causative virus of the new coronavirus infection (COVID-19) -Expected as a candidate for future therapeutic agents-

This time, Nagasaki University

* 1 (1-14 Bunkacho, Nagasaki City, Nagasaki Prefecture, President Shigeru Kono: Nagasaki University) and Neopharma Japan Co., Ltd.

* 2 (2-10-2 Fujimi, Chiyoda-ku, Tokyo, Representative Director) Satoshi Kawada: NPJ) conducted an infection experiment in cultured cells using SARS-CoV-2, which is the causative virus of the new coronavirus infection (“COVID-19”). As a result, 5-aminolevulinic acid We have discovered a strong infection-suppressing effect of

* 3 (hereinafter, "5-ALA"). This research was officially published in the international academic journal "Biochemical and Biophysical Research Communications" on February 8, 2021 (Japan time). Nagasaki University and NPJ released on October 29, 2020

* 4 There is an urgent need to develop effective treatments for the current spread of COVID-19 infection. 5-ALA is a naturally synthesized amino acid that is used for various purposes such as anti-cancer therapy and health foods due to its high bioavailability.

In this study, we showed that 5-ALA strongly suppresses infection with SARS-CoV-2, the causative virus of COVID-19, in cultured cells. This antiviral effect was observed in both human and non-human cells without overt cytotoxicity.

Therefore, 5-ALA is considered to be worth further research as a candidate for antiviral drug against COVID-19.

More

Supplements and COVID19  There are 2 products.

Showing 1 - 2 of 2 items
Поисковый анализ сайта Рейтинг@Mail.ru